Loading startup
Market data is refreshed once per day from public sources. Information may be incomplete or outdated — verify independently before making decisions. This is not investment advice.
DealFlow OS uses public web data and automated enrichment. Research may be incomplete, outdated, or incorrect. Verify important information before making investment or outreach decisions.
Evidence-bound summary — expand sections for movement, risks, and signals.
Memo snapshot · May 20, 2026, 5:58 PM
DealFlow OS uses public web data and automated enrichment. Research may be incomplete, outdated, or incorrect. Verify important information before making investment or outreach decisions.
Algen Bio Official CRISPR+AI drug discovery platform.
Latest: Venture (undisclosed) (Nov 2024). Investors: LifeSpan Vision Ventures. (High).
Unknown
Verified facts
+1 more in Recent movement below
Funding
Latest: Venture (undisclosed) (Nov 2024). Investors: LifeSpan Vision Ventures. (High).
Hiring
No hiring/careers evidence indexed (Low).
GitHub
No GitHub‑linked evidence indexed (Low).
Product / news
3 product/news‑styled row(s); headline risk without filings (High).
Traffic / social
No traffic/social evidence indexed (Low).
November 2024 investment in CRISPR+AI therapeutics platform; amount not disclosed.
No open roles indexed yet.
HTTP 404
HTTP 404
HTTP 404
HTTP 404
HTTP 404
HTTP 404
HTTP 404
HTTP 404
HTTP 404
HTTP 404
HTTP 404
HTTP 404
The score is an algorithmic estimate based on observed public company-level signals. It may be incomplete, stale, or inaccurate and is not investment, legal, tax, or business advice.
DealFlow score momentum
More runs will build history.
The score is an algorithmic estimate based on observed public company-level signals. It may be incomplete, stale, or inaccurate and is not investment, legal, tax, or business advice.
Latest momentum signal per category. Expand a card to inspect raw payloads.
Source types found
Strongest / recent news-style rows
LifeSpan Vision Ventures Invests in Algen Biotechnologies
Wed, May 20, 05:58 PM · confidence 88%high quality
https://www.lifespanvisionventures.com/post/lifespan-vision-ventures-invests-in-algen-biotechnologiesNews
News · Sun, May 10, 11:13 PM · confidence 90%high quality
https://www.algenbio.com/newsAlgen inks $555m AstraZeneca partnership
Wed, May 20, 05:58 PM · confidence 85%medium quality
https://www.bioxconomy.com/partnering/algen-inks-555m-astrazeneca-partnership-for-ai-powered-drug-discoveryNewest first · 5 event(s)
Official CRISPR+AI drug discovery platform.
November 2024 investment in CRISPR+AI therapeutics platform; amount not disclosed.
Source: Blog / news
News AboutTeamAdvisorsApproachPlatformPipelineNews & PublicationsNewsPublicationsTechnology & PipelineContact usNews & PublicationsThe NewsroomOctober 6, 2025Algen Biotechnologies Announces Multi-Target Partnership to Advance AI-Powered Drug Discovery in Immunology with AstraZenecaPressOctober 6, 2025S.F. biotech focused on AI and CRISPR lands potential half-billion-dollar deal with AstraZenecaPressOctober 6, 2025AI…
Source: News
News AboutTeamAdvisorsApproachPlatformPipelineNews & PublicationsNewsPublicationsTechnology & PipelineContact usNews & PublicationsThe NewsroomOctober 6, 2025Algen Biotechnologies Announces Multi-Target Partnership to Advance AI-Powered Drug Discovery in Immunology with AstraZenecaPressOctober 6, 2025S.F. biotech focused on AI and CRISPR lands potential half-billion-dollar deal with AstraZenecaPressOctober 6, 2025AI…
October 2025 strategic partnership coverage.
1 row(s)
Official CRISPR+AI drug discovery platform.
https://www.algenbio.com/2 row(s)
Source name: News
News AboutTeamAdvisorsApproachPlatformPipelineNews & PublicationsNewsPublicationsTechnology & PipelineContact usNews & PublicationsThe NewsroomOctober 6, 2025Algen Biotechnologies Announces Multi-Target Partnership to Advance AI-Powered Drug Discovery in Immunology with AstraZenecaPressOctober 6, 2025S.F. biotech focused on AI and CRISPR lands potential half-billion-dollar deal with AstraZenecaPressOctober 6, 2025AI…
https://www.algenbio.com/newsOctober 2025 strategic partnership coverage.
https://www.bioxconomy.com/partnering/algen-inks-555m-astrazeneca-partnership-for-ai-powered-drug-discovery1 row(s)
November 2024 investment in CRISPR+AI therapeutics platform; amount not disclosed.
https://www.lifespanvisionventures.com/post/lifespan-vision-ventures-invests-in-algen-biotechnologies1 row(s)
Source name: Blog / news
News AboutTeamAdvisorsApproachPlatformPipelineNews & PublicationsNewsPublicationsTechnology & PipelineContact usNews & PublicationsThe NewsroomOctober 6, 2025Algen Biotechnologies Announces Multi-Target Partnership to Advance AI-Powered Drug Discovery in Immunology with AstraZenecaPressOctober 6, 2025S.F. biotech focused on AI and CRISPR lands potential half-billion-dollar deal with AstraZenecaPressOctober 6, 2025AI…
https://www.algenbio.com/newsSign in as an active team member to view private notes, watchlist controls, transcript evidence, and interaction history.